Companies: 10,795·Total market cap: $144.5T
Basel Medical Group Ltd Ordinary Shares

Basel Medical Group Ltd Ordinary Shares

BMGLNASDAQHealthcare● Active
$0.59
+$0.05(+9.20%)
Market Cap$11170007
P/E Ratio—
52W High$5.07
52W Low$0.383
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Basel Medical Group Ltd Ordinary Shares (BMGL) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0002004489 · BMGL · NASDAQ · as of Jun 8, 2026

Filing snapshot

67
Total Filings
6-K
Latest Form
2026-06-05
Most Recent
2025
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0002004489 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2025-11-18
Fiscal Year End
Nov 18, 2025
Accession No.
0001493152-25-023940
Primary Document
form20-f.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0002004489 · Accession 0001493152-25-023940

Latest Key Filings

6-KQuarterly Report
6-K
2026-06-05
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
6-K
2026-06-05
View
3Initial Statement of Beneficial Ownership
3
2026-04-21
View
3Initial Statement of Beneficial Ownership
3
2026-04-15
View
3Initial Statement of Beneficial Ownership
3
2026-04-14
View
3Initial Statement of Beneficial Ownership
3
2026-04-14
View
3Initial Statement of Beneficial Ownership
3
2026-04-14
View
3Initial Statement of Beneficial Ownership
3
2026-04-14
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-03-30
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-03-24
View
20-F/A20-F/A
20-F/A
2026-03-13
View
3Initial Statement of Beneficial Ownership
3
2026-03-04
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-01-23
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-01-21
View
6-KCurrent Report (Foreign Issuer)
6-K
2025-12-01
View
20-FAnnual Report (Foreign Issuer)
20-F
2025-11-18
View
Showing 1–15 of 67 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0002004489  |  Exchange: NASDAQ · Healthcare

Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL) has submitted 67 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2025. As a Healthcare sector company with CIK 0002004489, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Basel Medical Group Ltd Ordinary Shares's most comprehensive regulatory disclosure. The most recent Basel Medical Group Ltd Ordinary Shares 10-K was filed on 2025-11-18 for fiscal year ending 2025. Historical BMGL 10-K annual reports are available from 2024 through 2025.

Investors researching Basel Medical Group Ltd Ordinary Shares SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
NTRB SEC Filings →PRPO SEC Filings →PIII SEC Filings →LDDD SEC Filings →IBIO SEC Filings →TLPH SEC Filings →MODD SEC Filings →INTS SEC Filings →
→ BMGL Financials→ BMGL Earnings→ BMGL Insider Trades

Frequently Asked Questions

BMGL SEC Filings · 8 questions

Basel Medical Group Ltd Ordinary Shares (BMGL) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 67 filings and access original documents at no cost. Basel Medical Group Ltd Ordinary Shares's CIK is 0002004489.

BMGL SEC filingsBasel Medical Group Ltd Ordinary Shares SEC documentsfind BMGL 10-K